Dietmar Geissler
Overview
Explore the profile of Dietmar Geissler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klocker J, Klocker-Kaiser U, Pipam W, Geissler D
Wien Med Wochenschr
. 2018 May;
168(13-14):350-360.
PMID: 29737478
A 3-week cancer rehabilitation program was conducted at the Humanomed Zentrum Althofen, comprising therapy of organic defects, lifestyle modification, and psycho-social support. Therapeutic efficacy was assessed in comprehensive surveys before...
2.
Almeida A, Prebet T, Itzykson R, Ramos F, Al-Ali H, Shammo J, et al.
Int J Mol Sci
. 2017 Apr;
18(4).
PMID: 28420120
Acute erythroleukemia (AEL) is a rare disease typically associated with a poor prognosis. The median survival ranges between 3-9 months from initial diagnosis. Hypomethylating agents (HMAs) have been shown to...
3.
Pleyer L, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, et al.
J Hematol Oncol
. 2016 Apr;
9:39.
PMID: 27084507
Background: The MDS-IWG and NCCN currently endorse both FAB and WHO classifications of MDS and AML, thus allowing patients with 20-30 % bone marrow blasts (AML20-30, formerly MDS-RAEB-t) to be...
4.
Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, et al.
Wien Klin Wochenschr
. 2015 Nov;
127(23-24):920-1.
PMID: 26613899
No abstract available.
5.
Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, et al.
Wien Klin Wochenschr
. 2015 Sep;
127(23-24):907-19.
PMID: 26373748
Iron deficiency and iron deficiency-associated anemia are common complications in cancer patients. Most iron deficient cancer patients present with functional iron deficiency (FID), a status with adequate storage iron, but...
6.
Thaler J, Greil R, Gaenzer J, Eisterer W, Tschmelitsch J, Samonigg H, et al.
Ann Oncol
. 2015 Mar;
26(4):822-825.
PMID: 25814651
No abstract available.
7.
Pleyer L, Burgstaller S, Girschikofsky M, Linkesch W, Stauder R, Pfeilstocker M, et al.
Ann Hematol
. 2014 Jun;
93(11):1825-38.
PMID: 24951123
Data on efficacy and safety of azacitidine in acute myeloid leukemia (AML) with >30 % bone marrow (BM) blasts are limited, and the drug can only be used off-label in...
8.
Pleyer L, Germing U, Sperr W, Linkesch W, Burgstaller S, Stauder R, et al.
Leuk Res
. 2014 Feb;
38(4):475-83.
PMID: 24522248
Recent data suggest that azacitidine may be beneficial in CMML. We report on 48 CMML-patients treated with azacitidine. Overall response rates were high (70% according to IWG-criteria, including 22% complete...
9.
Trifina E, Geissler D, Zwettler E, Klaushofer K, Mikosch P
Wien Med Wochenschr
. 2012 Apr;
162(5-6):110-4.
PMID: 22488034
A 44 yr-old female with osteoporosis had no relevant gastrointestinal symptoms and did not avoid any specific food. However, after prescription of a lactose-rich calcium supplementation, clinical symptoms suspicious for...
10.
Pabinger I, Gastl G, Steurer M, Sormann S, Fillitz M, Friedl J, et al.
Wien Klin Wochenschr
. 2012 Mar;
124(3-4):111-23.
PMID: 22382553
Immune Thrombocytopenia (ITP) is a rare and - in most patients - mild disease, but might be associated with severe or even life-threatening bleeding complications. The treatment of ITP has...